{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:42:36Z","timestamp":1788871356589,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ejpn.2014.07.005","type":"journal-article","created":{"date-parts":[[2014,7,28]],"date-time":"2014-07-28T22:20:45Z","timestamp":1406586045000},"page":"747-758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Safety and tolerability of zonisamide in paediatric patients with epilepsy"],"prefix":"10.1016","volume":"18","author":[{"given":"J. Helen","family":"Cross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Auvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Patten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2014.07.005_bib1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejpn.2013.02.003","article-title":"Advancing the management of childhood epilepsies","volume":"17","author":"Cross","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"issue":"Suppl. 2","key":"10.1016\/j.ejpn.2014.07.005_bib2","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1111\/j.1528-1157.1995.tb05998.x","article-title":"Antiepileptic drugs in pediatric practice","volume":"36","author":"Bourgeois","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2014.07.005_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1517\/14656566.2010.517194","article-title":"Pharmacotherapy for children and adolescents with epilepsy","volume":"12","author":"Verrotti","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ejpn.2014.07.005_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nurt.2006.10.004","article-title":"Clinical development of antiepileptic drugs for children","volume":"4","author":"Garofalo","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejpn.2014.07.005_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00003495-200868010-00002","article-title":"Antiepileptic drug development in children: considerations for a revisited strategy","volume":"68","author":"Chiron","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.ejpn.2014.07.005_bib6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/wnf.0b013e3180413d7d","article-title":"Clinical pharmacology and mechanism of action of zonisamide","volume":"30","author":"Biton","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.ejpn.2014.07.005_bib7","series-title":"Zonegran\u00ae summary of product characteristics","year":"2013"},{"key":"10.1016\/j.ejpn.2014.07.005_bib8","series-title":"Zonegran\u00ae prescribing information","year":"2012"},{"key":"10.1016\/j.ejpn.2014.07.005_bib9","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/epi.12233","article-title":"A randomized phase III trial of adjunctive zonisamide in pediatric patients with partial epilepsy","volume":"54","author":"Guerrini","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2014.07.005_bib10","series-title":"ICH harmonised tripartite guideline E3: structure and content of clinical study reports","author":"International Conference on Harmonisation","year":"1995"},{"key":"10.1016\/j.ejpn.2014.07.005_bib11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/17425255.4.4.493","article-title":"Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety","volume":"4","author":"Kothare","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.ejpn.2014.07.005_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-0404.2008.01119.x","article-title":"The impact of zonisamide on weight. A clinical study in 103 patients with epilepsy","volume":"119","author":"Wellmer","year":"2009","journal-title":"Acta Neurol Scand"},{"issue":"Suppl. 5","key":"10.1016\/j.ejpn.2014.07.005_bib13","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1111\/j.1528-1157.1999.tb00922.x","article-title":"Topiramate","volume":"40","author":"Glauser","year":"1999","journal-title":"Epilepsia"},{"issue":"Suppl. 2","key":"10.1016\/j.ejpn.2014.07.005_bib14","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.eplepsyres.2005.11.006","article-title":"Practical prescribing and long-term efficacy and safety of zonisamide","volume":"68","author":"Leppik","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ejpn.2014.07.005_bib15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1517\/14740338.2011.571201","article-title":"Drug safety evaluation of zonisamide for the treatment of epilepsy","volume":"10","author":"Zaccara","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.ejpn.2014.07.005_bib16","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1185\/030079907X210499","article-title":"Zonisamide and renal calculi in patients with epilepsy: how big an issue?","volume":"23","author":"Wroe","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ejpn.2014.07.005_bib17","first-page":"297","article-title":"The adverse event profile of zonisamide: a meta-analysis","volume":"128","author":"Verrotti","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ejpn.2014.07.005_bib18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/epi.12548","article-title":"Adjunctive zonisamide therapy in the long-term treatment of children with partial epilepsy: results of an open-label extension study of a phase III, randomized, double-blind, placebo-controlled trial","volume":"55","author":"Guerrini","year":"2014","journal-title":"Epilepsia"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379814001184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379814001184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T18:29:51Z","timestamp":1649788191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379814001184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1090379814001184"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2014.07.005","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and tolerability of zonisamide in paediatric patients with epilepsy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2014.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}